Benitec Biopharma Inc. Common Stock (BNTC)
PHARMACEUTICAL PREPARATIONS
- Headquarters
- United States
- Employees
- 19
- Market Cap
- $407M
About Benitec Biopharma Inc. Common Stock
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
SentiSense also tracks daily options readings for Benitec Biopharma Inc. Common Stock: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Benitec Biopharma Inc. Common Stock stock analysis, sentiment tracking, and market intelligence on SentiSense.